Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers

Journal:

Nature Nanotechnology

Published:

2025-05-21

DOI:

10.1038/s41565-025-01909-0

Affiliations:

4

Authors:

6

Go to article

Institutions	Authors	Share
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, China	3.500000	0.58
The Second Affiliated Hospital of Chongqing Medical University, CQMU, China	1.000000	0.17
University of Chinese Academy of Sciences (UCAS), China	1.000000	0.17
Zhengzhou University (ZZU), China	0.500000	0.08

Interested in Oncology and Carcinogenesis?